RNXT
RenovoRxยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RNXT Profile
Renovorx, Inc.
A clinical-stage biopharmaceutical company that developing local therapies for solid tumors
4546 El Camino Real, Suite B1, Los Altos, CA 94022
--
RenovoRx, Inc., was incorporated in Delaware on December 17, 2012. The Company is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for highly unmet medical needs with the goal of improving treatment outcomes for cancer patients undergoing treatment. The Company's proprietary Transarterial Microperfusion (TAMPT) treatment platform is designed to ensure precise treatment delivery to directly target the tumor while potentially minimizing the toxicity of the treatment relative to systemic (intravenous (referred to as "IV ") treatment).
